Fig. 5: Bacteria as predictive factors for immunotherapy outcomes in various bacterial phyla and mono-/poly-bacterial models.
From: Microbiome meets immunotherapy: unlocking the hidden predictors of immune checkpoint inhibitors
Association of different bacterial phyla with overall survival (OS) (A) and progression free survival (PFS) (B). Comparison of mono-bacterial vs. poly-bacterial models for OS (C) and PFS (D).
